Inactivated vaccine Covaxin/BBV152: A systematic review

We systematically reviewed and summarized studies focusing on Bharat Biotech’s Whole Virion Inactivated Corona Virus Antigen BBV152 (Covaxin), which is India’s indigenous response to fighting the SARS-CoV-2 pandemic. Studies were searched for data on the efficacy, immunogenicity, and safety profile...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Tousief Irshad, Rishi, Saqib, Irshad, Summaiya, Aggarwal, Jyoti, Happa, Karan, Mansoor, Sheikh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395719/
https://www.ncbi.nlm.nih.gov/pubmed/36016940
http://dx.doi.org/10.3389/fimmu.2022.863162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395719/
https://www.ncbi.nlm.nih.gov/pubmed/36016940
http://dx.doi.org/10.3389/fimmu.2022.863162

Ejemplares similares